4
Changes in Ownership
Kiniksa Pharmaceuticals International, plc Filed Acc 0001415889-25-008117
CHIEF ACCOUNTING OFFICER sold 9,051 shares at $22.45 ($203,195)
- CHIEF ACCOUNTING OFFICER acquired 9,051 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Megna Michael R CHIEF ACCOUNTING OFFICER | 2025-03-12 | Option exercise 10b5-1 | +9,051 | $11.10 | $100,466 | 35,579 | D |
| Megna Michael R CHIEF ACCOUNTING OFFICER | 2025-03-12 | Sale 10b5-1 | −9,051 | $22.45 | $203,195 | 26,528 | D |
| Derivatives | |||||||
| Megna Michael R CHIEF ACCOUNTING OFFICER | 2025-03-12 | Option exercise · Share Option 10b5-1 | −9,051 | 13,763 | D | ||
| Open-market sales · 9,051 sh · avg $22.45 · $203,195 | |||||||
Loading xslF345X05/form4-03142025_080322.xml…